Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ScieGen Pharmaceuticals
Hauppauge, New York, United Statessciegenpharm.com ↗
- Ownership
- Private
- Employees
- ~129
- Development stage
- Other
01
Overview
ScieGen Pharmaceuticals is a US-based generic drug manufacturer with over 75 ANDAs filed and more than 50 approved products across multiple therapeutic areas. The company operates cGMP manufacturing facilities in Hauppauge, NY with an annual capacity of over 10 billion tablets/capsules. Its portfolio includes widely used small-molecule generics for chronic and acute conditions[1][2][5][10].
- Therapeutic areas
- NeurologyPsychiatryEndocrinologyOtherImmunologyCardiovascular
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on ScieGen Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ScieGen Pharmaceuticals.